Pain Assessment and Indications for Morphine in Cameroon: Results of a Cross-Sectional Survey among Healthcare Professionals ()
1. Introduction
Pain remains a major public health problem, particularly in oncology and palliative care, where morphine continues to be one of the cornerstone treatments for moderate to severe pain [1] [2]. Despite decades of international recommendations [3]-[5], gaps persist between theoretical principles such as structured pain assessment, dose titration, and monitoring of adverse effects and their bedside implementation, especially in low- and middle-income countries [6] [7].
Accurate pain assessment is a prerequisite for appropriate therapeutic decision-making. Pain intensity scales, particularly the Numeric Rating Scale (NRS 0 - 10), are widely used and supported by robust evidence of validity and clinical utility across various settings [8]-[13]. However, translating these measurements into rational opioid prescribing requires specific competencies related to morphine’s mechanism of action, intravenous and oral titration, prevention of adverse effects (notably constipation), and regulatory considerations [1] [2] [14].
In many sub-Saharan African countries, access to opioid analgesics remains hindered by supply shortages, limited distribution networks, restrictive regulatory frameworks, beliefs regarding the risk of addiction, and insufficient training of healthcare personnel [6] [7] [15]-[17]. Cameroon fits within this broader context. Although recent efforts have aimed to strengthen palliative care services and improve morphine availability, persistent challenges related to policy, training, and supply chains remain [18]. These systemic constraints interact with healthcare providers’ knowledge, attitudes, and practices, which previous studies have shown to be highly heterogeneous depending on discipline, professional experience, and practice setting [19] [20].
From a clinical perspective, recommended strategies for cancer pain and certain forms of severe acute pain rely on stepwise approaches that integrate morphine use, dose adjustment, and the addition of adjuvant therapies when necessary, with well-documented benefits that are nevertheless inconsistently translated into routine practice [2] [3] [5] [21]. More recent work has proposed updates to the stepwise approach to incorporate complementary or interventional strategies when analgesic response is insufficient [1] [14]. In this context, assessing healthcare professionals’ level of proficiency from pain assessment to indications, mechanisms, and prescribing of morphine is essential to guide targeted training, adapt clinical protocols, and inform public health policies [7] [16] [18]. We therefore conducted a cross-sectional survey among Cameroonian healthcare professionals to describe levels of knowledge regarding pain assessment and indications for morphine, understanding of morphine’s mechanism of action and prescribing rules, and clinical practices related to morphine use and pain management, as well as to identify priorities for training and organizational capacity building within the Cameroonian context.
2. Methods
Study design and setting
We conducted a cross-sectional Knowledge-Attitudes-Practices (KAP) study in Cameroon between 1 May and 30 June 2025 across public and private healthcare facilities (hospitals, clinics, and medical offices).
Questionnaire development and validation
The survey instrument was developed through a structured multi-step process to ensure content validity and internal consistency.
Conceptual framework and domains
The questionnaire was constructed around three predefined domains:
Domain 1: Pain assessment and indications for morphine (12 items).
Domain 2: Morphine mechanism of action and prescribing rules (10 items).
Domain 3: Clinical practices related to morphine use and pain management (10 items).
The total instrument included 32 knowledge/practice items in addition to 8 sociodemographic and professional variables.
Source of items
Items were derived from:
International guidelines on cancer pain and opioid prescribing (WHO analgesic ladder, palliative care recommendations).
Peer-reviewed literature on morphine titration, opioid adverse-effect prevention, and pain assessment scales.
National clinical practice realities in Cameroon (availability constraints, regulatory considerations).
Items were formulated as single-best-answer multiple-choice questions or dichotomous (True/False/Don’t know) items. All knowledge items were closed-ended to reduce interpretation variability.
Expert review
The preliminary questionnaire was reviewed by a panel of five experts (two anesthesiologist-intensivists, one oncologist, one palliative care specialist, and one epidemiologist). Reviewers evaluated clarity, relevance, and representativeness of each item within its domain. Minor wording adjustments were made to improve clarity and eliminate ambiguity.
Pilot Testing
A pilot test was conducted among 30 healthcare professionals not included in the final sample. The objectives were to assess comprehension, wording clarity, average completion time, technical functionality (online and paper formats), and item discrimination. Based on pilot feedback, three items were rephrased and one item with poor discrimination was removed.
Internal Consistency
Internal consistency reliability was evaluated using Cronbach’s alpha for each domain in the pilot sample:
Domain 1 (Assessment/Indications): α = 0.78.
Domain 2 (Mechanism/Prescribing rules): α = 0.74.
Domain 3 (Practices): α = 0.81.
These values were considered acceptable for exploratory KAP research and supported the internal coherence of domain-specific scores.
Operationalization of the “Mechanism/Prescribing Rules” Domain
This domain (10 items) was specifically designed to assess operational knowledge required for safe morphine prescribing. Items covered:
Pharmacodynamic mechanism (µ-opioid receptor agonism, central modulation of nociception).
Basic pharmacokinetics (oral vs intravenous onset, duration of action).
Initial dosing principles in opioid-naïve adults.
Intravenous titration steps in severe acute pain.
Oral dose conversion after IV titration.
Equianalgesic conversion principles.
Recognition of major adverse effects (respiratory depression, sedation).
Systematic prevention of opioid-induced constipation.
Contraindications and dose adjustment principles (renal impairment).
Regulatory and prescription documentation requirements.
Each item was scored dichotomously (correct = 1; incorrect or “don’t know” = 0). The domain score ranged from 0 to 10 and was converted into a percentage (0% - 100%). Adequate knowledge was predefined as >60% (≥6/10 correct answers).
Score Distribution and Item-Level Performance
The overall score distribution for this domain in the full sample (n = 975) was markedly skewed toward low values. The median score was 2/10 (20%), with an Interquartile Range (IQR) of 1 - 3 correct answers (10% - 30%). Only 14 participants (1.4%) achieved ≥6/10 correct responses.
Item-level analysis showed heterogeneous performance across technical prescribing components, particularly dose conversion, titration algorithms, and regulatory aspects.
Target Population, Eligibility Criteria, and Recruitment
Eligible participants were practicing healthcare professionals (physicians, nurses, residents, etc.) during the study period who provided informed consent to participate. Recruitment relied on non-probability sampling: the questionnaire was disseminated within hospital departments and clinics and relayed through medical managers and professional networks.
Sample Size
A total of 975 participants were included. The sample size was designed to provide estimates of proportions with a margin of error ≤ 4% for prevalences around 50% and to allow exploratory inter-specialty comparisons with adequate statistical power.
Data Collection Tool and Variables
Data were collected using the standardized questionnaire administered both in person (paper-based, by trained investigators) and online (identical Google Forms version). Variables included sociodemographic and professional characteristics (profession, specialty, years of experience, type of healthcare facility), knowledge of pain assessment and indications for morphine, knowledge of morphine’s mechanism of action and prescribing rules, and clinical practices related to morphine use and pain management (titration, prevention of constipation, documentation).
Operational Definitions and Scoring
Each knowledge item was scored 1 point for a correct response and 0 for incorrect or “don’t know” responses. Domain scores were calculated as the percentage of correct responses within each domain. Aggregated domain scores were dichotomized into binary variables (“adequate” vs “insufficient”) using a predefined threshold of >60% correct responses.
Data Collection Procedures and Quality Assurance
Investigators received brief training focusing on standardization of instructions, neutrality, and management of non-responses. Paper questionnaires were double-entered and reconciled, while online data were exported and merged after consistency checks.
Bias Management
To minimize information bias, questions were closed-ended and neutrally worded; anonymous administration was intended to reduce social desirability bias. Selection bias related to non-probability sampling was acknowledged.
Informed Consent
Participation was voluntary. For paper-based administration, participants received written information explaining the study objectives, confidentiality safeguards, and the right to decline or withdraw without consequences. Written informed consent was obtained before questionnaire completion. For the online version (Google Forms), an electronic information sheet was presented on the first page, and participants were required to actively confirm consent before accessing the questionnaire.
Data Protection and Confidentiality
No directly identifying personal data was collected. Paper questionnaires were stored in locked cabinets accessible only to the principal investigators. Online data were stored on a password-protected institutional account and exported to encrypted files for analysis. Access to the dataset was restricted to the research team. Data were analyzed in aggregated form to prevent individual identification. After completion of the study, data archiving and retention followed institutional and national data-protection regulations.
Given the mixed paper and online data-collection strategy, special attention was paid to ensuring equivalence of information provided to participants and identical consent language across formats.
Missing Data
Rates of missing data were reported for each variable; comparative analyses were conducted using complete-case analysis when appropriate.
Statistical Analysis
Statistical analyses were performed using R software version 4.5.0 for Windows. Categorical variables were described using counts and percentages. Bivariate comparisons by specialty were conducted using Pearson’s chi-square test (or Fisher’s exact test when appropriate). Statistical significance was set at p < 0.05 (two-sided). Main results are presented in tables.
Multivariable Analysis (Independent Correlates)
To identify independent correlates of adequate knowledge and adequate practices beyond bivariate specialty comparisons, we specified multivariable logistic regression models using the already collected predictors: specialty, profession, prior pain-training status (certification/diploma or prior training vs none), years of professional experience (categorical), and practice setting (public hospital vs other). Separate models were planned for each binary outcome:
Adequate knowledge of pain assessment and indications for morphine (yes/no);
Adequate knowledge of morphine’s mechanism of action and prescribing rules (yes/no);
Adequate knowledge of clinical practices related to morphine use and pain management (yes/no).
3. Results
General Characteristics of the Study Population
Most participants were physicians (n = 897; 92%), primarily from anesthesiology-intensive care specialties (n = 186; 20%). Nearly half had 1 - 5 years of professional experience (n = 436; 45%), and the majority practiced in public hospitals (n = 847; 89%) (Table 1).
Table 1. General characteristics.
Variables |
N = 975 |
Profession |
|
Physician |
897 (92%) |
Nurse |
55 (5.6%) |
Resident |
23 (2.4%) |
Speciality |
|
Anaesthesiologist-Intensivist |
186 (20%) |
General Practitioner |
180 (19%) |
Oncologist |
91 (9.7%) |
Surgeon |
82 (8.7%) |
Cardiologist |
49 (5.2%) |
Obstetrician-Gynaecologist |
46 (4.9%) |
ENT (Otolaryngologist) |
37 (3.9%) |
Emergency Medicine |
36 (3.8%) |
Anaesthesiology-Intensive Care Resident |
24 (2.6%) |
Pain Medicine and Palliative Care |
20 (2.1%) |
Haematologist |
16 (1.7%) |
Radiologist |
16 (1.7%) |
Oncology Resident (female) |
16 (1.7%) |
Neurologist |
13 (1.4%) |
Paediatrician |
13 (1.4%) |
Emergency Medicine Resident |
13 (1.4%) |
Nephrologist |
12 (1.3%) |
Hepato-Gastroenterologist |
11 (1.2%) |
Nurse (female) |
10 (1.1%) |
Internist |
10 (1.1%) |
Geriatric Internist |
9 (1.0%) |
Gastroenterologist |
8 (0.9%) |
Neurology Resident |
7 (0.7%) |
Radiation Therapy Resident |
7 (0.7%) |
Radiation Oncologist |
5 (0.5%) |
Dermatologist |
4 (0.4%) |
Forensic Physician |
4 (0.4%) |
Obstetrics and Gynecology Resident |
4 (0.4%) |
Pediatrics Resident (female) |
4 (0.4%) |
Infectious Disease Specialist |
3 (0.3%) |
Surgery Resident |
3 (0.3%) |
Sports Medicine Physician |
1 (0.1%) |
Pulmonologist |
1 (0.1%) |
Certification or university diploma in pain management |
|
No, but I am interested in training in this field. |
426 (44%) |
No, I have no specific training in pain management. |
394 (40%) |
Yes, I am trained in anesthesiology-intensive care with a focus on pain management. |
63 (6.5%) |
Yes, I have a certification or specific training in pain management. |
57 (5.8%) |
Yes, I have a specialization in palliative care. |
18 (1.8%) |
Yes, I have a university diploma in chronic pain management. |
17 (1.7%) |
Professional experience |
|
1 to 5 years |
436 (45%) |
6 to 10 years |
230 (24%) |
More than 10 years |
223 (23%) |
Variables |
N = 975 |
Less than one year |
80 (8.3%) |
Practice setting |
|
Public hospital |
847 (89%) |
Private clinic |
69 (7.3%) |
Medical office |
17 (1.8%) |
NGO |
8 (0.8%) |
Semi-public (parastatal) |
7 (0.7%) |
Level of Knowledge on Pain Assessment and Indications for Morphine by Specialty
Overall, 80.3% (n = 783) of participants demonstrated adequate knowledge regarding pain assessment and indications for morphine. Specialties showing particularly high levels of knowledge included oncology (91/91), emergency medicine (36/36), pain medicine/palliative care (20/20), hematology (16/16), and radiation oncology/oncology residents (16/16), as well as several medical specialties, namely neurology (13/13), nephrology (12/12), hepatogastroenterology (11/11), internal medicine (10/10), and geriatrics-internal medicine (9/9) (Table 2).
Table 2. Knowledge of pain assessment and indications for morphine by specialty.
Characteristic |
Total
N = 9751 |
No
N = 1921 |
Yes
N = 7831 |
p-value2 |
Specialty |
|
|
|
<0.001 |
Anesthesiologist-Intensivist |
186 (20%) |
27 (2.9%) |
159 (17%) |
|
General Practitioner |
180 (19%) |
37 (3.9%) |
143 (15%) |
|
Oncologist |
91 (9.7%) |
0 (0%) |
91 (9.7%) |
|
Surgeon |
82 (8.7%) |
33 (3.5%) |
49 (5.2%) |
|
Cardiologist |
49 (5.2%) |
9 (1.0%) |
40 (4.3%) |
|
Obstetrician-Gynecologist |
46 (4.9%) |
31 (3.3%) |
15 (1.6%) |
|
Otolaryngologist |
37 (3.9%) |
33 (3.5%) |
4 (0.4%) |
|
Emergency Medicine |
36 (3.8%) |
0 (0%) |
36 (3.8%) |
|
Anesthesiology-Intensive Care Resident |
24 (2.6%) |
5 (0.5%) |
19 (2.0%) |
|
Pain Medicine and Palliative Care |
20 (2.1%) |
0 (0%) |
20 (2.1%) |
|
Hematologist |
16 (1.7%) |
0 (0%) |
16 (1.7%) |
|
Radiologist |
16 (1.7%) |
3 (0.3%) |
13 (1.4%) |
|
Oncology Resident |
16 (1.7%) |
0 (0%) |
16 (1.7%) |
|
Neurologist |
13 (1.4%) |
0 (0%) |
13 (1.4%) |
|
Pediatrician |
13 (1.4%) |
3 (0.3%) |
10 (1.1%) |
|
Emergency Medicine Resident |
13 (1.4%) |
0 (0%) |
13 (1.4%) |
|
Nephrologist |
12 (1.3%) |
0 (0%) |
12 (1.3%) |
|
Hepatogastroenterologist |
11 (1.2%) |
0 (0%) |
11 (1.2%) |
|
Nurse |
10 (1.1%) |
4 (0.4%) |
6 (0.6%) |
|
Internist |
10 (1.1%) |
0 (0%) |
10 (1.1%) |
|
Geriatric Internist |
9 (1.0%) |
0 (0%) |
9 (1.0%) |
|
Gastroenterologist |
8 (0.9%) |
0 (0%) |
8 (0.9%) |
|
Neurology Resident |
7 (0.7%) |
0 (0%) |
7 (0.7%) |
|
Radiation Therapy Resident |
7 (0.7%) |
0 (0%) |
7 (0.7%) |
|
Radiation Oncologist |
5 (0.5%) |
0 (0%) |
5 (0.5%) |
|
Dermatologist |
4 (0.4%) |
0 (0%) |
4 (0.4%) |
|
Forensic Physician |
4 (0.4%) |
0 (0%) |
4 (0.4%) |
|
Obstetrics and Gynecology Resident |
4 (0.4%) |
0 (0%) |
4 (0.4%) |
|
Pediatrics Resident |
4 (0.4%) |
0 (0%) |
4 (0.4%) |
|
Infectious Disease Specialist |
3 (0.3%) |
0 (0%) |
3 (0.3%) |
|
Surgery Resident |
3 (0.3%) |
0 (0%) |
3 (0.3%) |
|
Sports Medicine Physician |
1 (0.1%) |
0 (0%) |
1 (0.1%) |
|
Pulmonologist |
1 (0.1%) |
1 (0.1%) |
0 (0%) |
|
1n (%). 2Pearson’s chi-squared test.
Knowledge of Morphine’s Mechanism of Action and Prescribing Rules by Specialty
Knowledge in this domain was very limited. Only 1.4% (14/975) of participants demonstrated adequate knowledge of morphine’s mechanism of action and prescribing rules. The specialties concerned were oncology (n = 3) and pain medicine/palliative care (Table 3).
Table 3. Knowledge of morphine’s mechanism of action and prescribing rules by specialty.
Characteristic |
Total N = 9751 |
No N = 9611 |
Yes N = 141 |
p-value2 |
Specialty |
|
|
|
<0.001 |
Anesthesiologist-Intensivist |
186 (20%) |
186 (20%) |
0 (0%) |
|
General Practitioner |
180 (19%) |
180 (19%) |
0 (0%) |
|
Oncologist |
91 (9.7%) |
88 (9.4%) |
3 (0.3%) |
|
Surgeon |
82 (8.7%) |
82 (8.7%) |
0 (0%) |
|
Cardiologist |
49 (5.2%) |
49 (5.2%) |
0 (0%) |
|
Obstetrician-Gynecologist |
46 (4.9%) |
46 (4.9%) |
0 (0%) |
|
Otolaryngologist |
37 (3.9%) |
37 (3.9%) |
0 (0%) |
|
Emergency Medicine |
36 (3.8%) |
36 (3.8%) |
0 (0%) |
|
Anesthesiology-Intensive Care Resident |
24 (2.6%) |
24 (2.6%) |
0 (0%) |
|
Pain Medicine and Palliative Care |
20 (2.1%) |
9 (1.0%) |
11 (1.2%) |
|
Hematologist |
16 (1.7%) |
16 (1.7%) |
0 (0%) |
|
Radiologist |
16 (1.7%) |
16 (1.7%) |
0 (0%) |
|
Oncology Resident |
16 (1.7%) |
16 (1.7%) |
0 (0%) |
|
Neurologist |
13 (1.4%) |
13 (1.4%) |
0 (0%) |
|
Pediatrician |
13 (1.4%) |
13 (1.4%) |
0 (0%) |
|
Emergency Medicine Resident |
13 (1.4%) |
13 (1.4%) |
0 (0%) |
|
Nephrologist |
12 (1.3%) |
12 (1.3%) |
0 (0%) |
|
Hepatogastroenterologist |
11 (1.2%) |
11 (1.2%) |
0 (0%) |
|
Nurse |
10 (1.1%) |
10 (1.1%) |
0 (0%) |
|
Internist |
10 (1.1%) |
10 (1.1%) |
0 (0%) |
|
Geriatric Internist |
9 (1.0%) |
9 (1.0%) |
0 (0%) |
|
Gastroenterologist |
8 (0.9%) |
8 (0.9%) |
0 (0%) |
|
Neurology Resident |
7 (0.7%) |
7 (0.7%) |
0 (0%) |
|
Radiation Therapy Resident |
7 (0.7%) |
7 (0.7%) |
0 (0%) |
|
Radiation Oncologist |
5 (0.5%) |
5 (0.5%) |
0 (0%) |
|
Dermatologist |
4 (0.4%) |
4 (0.4%) |
0 (0%) |
|
Forensic Physician |
4 (0.4%) |
4 (0.4%) |
0 (0%) |
|
Obstetrics and Gynecology Resident |
4 (0.4%) |
4 (0.4%) |
0 (0%) |
|
Pediatrics Resident |
4 (0.4%) |
4 (0.4%) |
0 (0%) |
|
Infectious Disease Specialist |
3 (0.3%) |
3 (0.3%) |
0 (0%) |
|
Surgery Resident |
3 (0.3%) |
3 (0.3%) |
0 (0%) |
|
Sports Medicine Physician |
1 (0.1%) |
1 (0.1%) |
0 (0%) |
|
Pulmonologist |
1 (0.1%) |
1 (0.1%) |
0 (0%) |
|
1n (%). 2Pearson’s chi-squared test.
Knowledge of Clinical Practices Related to Morphine Use and Pain Management
With regard to clinical practices and pain management, 52.9% (516/975) of participants demonstrated adequate knowledge. The highest knowledge levels were observed in specialties closely related to analgesia, including pain medicine/palliative care (16/20), hematology (16/16), neurology (13/13), internal medicine (10/10), geriatrics–internal medicine (9/9), gastroenterology (8/8), neurology residents (7/7), radiation therapy residents (7/7), forensic medicine (4/4), and obstetrics and gynecology residents (4/4). Intermediate levels of knowledge were observed in anesthesiology-intensive care (124/186), oncology (53/91), pediatrics (7/13), anesthesiology-intensive care residents (13/24), and hepatogastroenterology (6/11) (Table 4).
Table 4. Knowledge of clinical practices related to morphine use and pain management.
Characteristic |
Total N = 9751 |
No N = 4591 |
Yes N = 5161 |
p-value2 |
Specialty |
|
|
|
<0.001 |
Anesthesiologist-Intensivist |
186 (20%) |
62 (6.6%) |
124 (13%) |
|
General Practitioner |
180 (19%) |
95 (10%) |
85 (9.0%) |
|
Oncologist |
91 (9.7%) |
38 (4.0%) |
53 (5.6%) |
|
Surgeon |
82 (8.7%) |
59 (6.3%) |
23 (2.4%) |
|
Cardiologist |
49 (5.2%) |
29 (3.1%) |
20 (2.1%) |
|
Obstetrician-Gynecologist |
46 (4.9%) |
24 (2.6%) |
22 (2.3%) |
|
Otolaryngologist |
37 (3.9%) |
37 (3.9%) |
0 (0%) |
|
Emergency Medicine |
36 (3.8%) |
21 (2.2%) |
15 (1.6%) |
|
Anesthesiology-Intensive Care Resident |
24 (2.6%) |
11 (1.2%) |
13 (1.4%) |
|
Pain Medicine and Palliative Care |
20 (2.1%) |
4 (0.4%) |
16 (1.7%) |
|
Hematologist |
16 (1.7%) |
0 (0%) |
16 (1.7%) |
|
Radiologist |
16 (1.7%) |
13 (1.4%) |
3 (0.3%) |
|
Oncology Resident |
16 (1.7%) |
4 (0.4%) |
12 (1.3%) |
|
Neurologist |
13 (1.4%) |
0 (0%) |
13 (1.4%) |
|
Pediatrician |
13 (1.4%) |
6 (0.6%) |
7 (0.7%) |
|
Emergency Medicine Resident |
13 (1.4%) |
0 (0%) |
13 (1.4%) |
|
Nephrologist |
12 (1.3%) |
12 (1.3%) |
0 (0%) |
|
Hepatogastroenterologist |
11 (1.2%) |
5 (0.5%) |
6 (0.6%) |
|
Nurse |
10 (1.1%) |
6 (0.6%) |
4 (0.4%) |
|
Internist |
10 (1.1%) |
0 (0%) |
10 (1.1%) |
|
Geriatric Internist |
9 (1.0%) |
0 (0%) |
9 (1.0%) |
|
Gastroenterologist |
8 (0.9%) |
0 (0%) |
8 (0.9%) |
|
Neurology Resident |
7 (0.7%) |
0 (0%) |
7 (0.7%) |
|
Radiation Therapy Resident |
7 (0.7%) |
0 (0%) |
7 (0.7%) |
|
Radiation Oncologist |
5 (0.5%) |
5 (0.5%) |
0 (0%) |
|
Dermatologist |
4 (0.4%) |
4 (0.4%) |
0 (0%) |
|
Forensic Physician |
4 (0.4%) |
0 (0%) |
4 (0.4%) |
|
Obstetrics and Gynecology
Resident |
4 (0.4%) |
0 (0%) |
4 (0.4%) |
|
Pediatrics Resident |
4 (0.4%) |
4 (0.4%) |
0 (0%) |
|
Infectious Disease Specialist |
3 (0.3%) |
3 (0.3%) |
0 (0%) |
|
Surgery Resident |
3 (0.3%) |
3 (0.3%) |
0 (0%) |
|
Sports Medicine Physician |
1 (0.1%) |
1 (0.1%) |
0 (0%) |
|
Pulmonologist |
1 (0.1%) |
1 (0.1%) |
0 (0%) |
|
1n (%). 2Pearson’s chi-squared test.
Recommendations (by participants)
The majority of participants recommended the organization of regular training programs (n = 775; 80%) (Table 5).
Table 5. Participants’ recommendations.
Recommandations |
N = 9751 |
Organize regular training programs |
775 (80%) |
Implement standard protocols |
169 (17%) |
Improve access to opioid analgesics |
12 (1.2%) |
Strengthen awareness and education on stigma |
12 (1.2%) |
None |
7 (0.7%) |
1n (%).
4. Discussion
Pain remains a major public health challenge in Cameroon, where morphine is the reference analgesic for moderate to severe pain but remains underutilized due to multiple barriers, including heterogeneous training among healthcare providers, opioid-related fears, and constraints related to access and regulation. In a context where the demand for palliative care is increasing and local initiatives to produce and distribute morphine within healthcare facilities are being actively implemented, it is crucial to objectively assess healthcare professionals’ actual level of proficiency in order to guide continuing education, harmonize protocols, and ensure safe use. This study was therefore warranted to measure, among Cameroonian healthcare professionals, knowledge of pain assessment and indications for morphine, understanding of morphine’s mechanism of action and prescribing rules, and clinical knowledge and practices related to pain management, as well as to identify training and organizational priorities necessary for safe and rational access to opioid analgesics.
In this national survey of Cameroonian healthcare professionals, we observed a marked contrast between high levels of knowledge regarding pain assessment and indications for morphine and, conversely, limited mastery of morphine’s mechanism of action and prescribing rules, along with an intermediate level of practical knowledge. This discrepancy between “what to prescribe” and “how/why to prescribe” is consistent with the international literature. Although morphine remains a cornerstone of moderate to severe pain management and a central component of the World Health Organization (WHO) analgesic ladder [3]-[5] [22], its operational translation—intravenous (IV) and oral (PO) titration, systematic prevention of constipation, monitoring of adverse effects, and proper documentation—remains uneven, particularly in resource-limited settings [6] [7] [16].
Our findings are in line with studies showing the presence of systemic barriers to secure opioid access in Sub-Saharan Africa, including limited availability, restrictive regulatory frameworks, unreliable supply chains, and reluctance driven by beliefs and stigma [7] [16] [17] [23]-[25]. Recent syntheses focusing on Cameroon further highlight that the availability of oral morphine and palliative care capacity still requires strengthening despite notable progress [18]. This structural context may partly explain the limited practical exposure and prescribing caution observed in certain specialties.
From a clinical perspective, several key technical competencies are involved. First, standardized pain assessment using the Numeric Rating Scale (0 - 10) has demonstrated validity and clinical utility in acute and emergency care settings; however, its implementation and caregiver-patient concordance remain suboptimal [26]-[29]. Second, morphine titration rapid IV titration for severe pain and subsequent oral adjustment is supported by multiple protocol-based studies [30]-[33], but requires structured training combined with supervision to avoid under- or overdosing. Finally, systematic prevention of opioid-induced constipation through concomitant laxative prescription is recommended and associated with improved outcomes [34]-[36], yet its implementation remains variable. The “moderate” level of practical knowledge observed in our study is therefore consistent with the literature: while the tools are available, their implementation and the securing of practices require targeted support.
Beyond technical competencies, healthcare providers’ attitudes and beliefs significantly influence opioid use. Several reviews and studies have highlighted the impact of stigma toward opioids and opioid use disorders, which may translate into reluctance to prescribe or refer patients appropriately [35] [37] [38]. Our observation of a strong demand for regular training and standardized protocols aligns with evidence showing that educational interventions can improve knowledge and, in some cases, prescribing practices [39] [40], although large-scale implementation requires organizational support [41].
In the short term, our results support the implementation of continuing education programs focused on morphine titration, prevention of adverse effects (notably constipation), and regulatory aspects; dissemination of simple, illustrated national protocols (NRS 0 - 10 assessment, IV/PO algorithms, safety checklists); integration of anti-stigma actions into undergraduate and continuing education; and ensuring a reliable supply of oral morphine and adjuvants (laxatives), in line with palliative care priorities in Cameroon and regional/international recommendations. In the medium term, impact evaluations (audit and feedback, indicators of prescribing and access) will be necessary to assess the adoption of best practices and improvements in analgesia.
Strengths and limitations of the study: The sample size and the inclusion of multiple professional categories (physicians and other healthcare professionals) represent major strengths of this study. However, non-probability sampling and self-reported data may have led to overestimation of perceived knowledge. In addition, inter-specialty heterogeneity and partial reliance on online data collection may have introduced selection and information biases.
5. Conclusions
Our study highlights a satisfactory baseline of knowledge regarding pain assessment and indications for morphine, but identifies substantial gaps in understanding of morphine’s mechanism of action, prescribing rules, and certain key practical skills. In the context of expanding palliative care in Cameroon, the combined implementation of regular training, standardized protocols, and secured access to morphine should be prioritized to bring clinical practice closer to international standards and improve pain relief.
Ethical Considerations
This study was conducted in accordance with the principles of the Declaration of Helsinki. Ethical approval was obtained from the competent institutional ethics committee prior to data collection. The study protocol, questionnaire, and consent procedures were reviewed and approved before implementation.